Film-coated tablets containing Thiamine BP 75 mg for prevention or treatment of thiamine (Vitamin B1) deficiency when clinically appropriate.
Each film-coated tablet contains: Thiamine BP 75 mg.
Dosage form: Film-coated tablet.
Therapeutic category: Vitamin B1 / Nutritional Supplement / Thiamine Deficiency Management.
Usage: Prevention and treatment of thiamine deficiency and related deficiency states under professional guidance.
B2B enquiry: Contract manufacturing and export enquiries: +91 7710003340.
Thiamine Tablets BP (Vitamin B1) is listed for pharmaceutical business-to-business enquiries. Exact active ingredients, formulation, strength, pack configuration and manufacturer details should be confirmed against the product label and approved technical documentation before ordering.
Healthy Life Pharma Pvt. Ltd. offers B2B manufacturing and supply support for Thiamine Tablets BP 75 mg. Thiamine (Vitamin B1) is a water-soluble vitamin required for carbohydrate metabolism, cellular energy production and normal nervous-system function.
Oral thiamine products may be used to prevent or treat thiamine deficiency when the oral route is appropriate. Patients with severe deficiency, suspected Wernicke encephalopathy, persistent vomiting, malabsorption or other high-risk clinical states may require urgent assessment and parenteral thiamine rather than relying on an oral tablet alone.
Manufacturing, export, WHO-GMP and other certification claims should be confirmed against current valid documents before publication or tender submission.
| Product Name | Thiamine Tablets BP 75 mg |
|---|---|
| Generic Name | Thiamine Tablets / Vitamin B1 Tablets |
| Confirmed Strength | 75 mg |
| Composition | Thiamine BP 75 mg per film-coated tablet |
| Dosage Form | Film-coated tablet |
| Therapeutic Class | Vitamin B1 / Nutritional Supplement |
| Standard | BP claim as supplied; final product specification should follow the registered dossier |
| Packaging | To be confirmed from the approved commercial pack |
| Shelf Life | To be established from approved stability data for the final formulation and pack |
The supplied product composition confirms 75 mg. Other strengths mentioned in general marketing copy are not presented here as confirmed SKUs.
Thiamine formulations require controls appropriate to the actual API form, excipients, coating and packaging system.
Specific claims such as exact relative humidity limits, granulation method, Opadry system, dedicated equipment or Alu-Alu packaging should be published only when supported by the actual manufacturing and stability records.
Finished-product testing should follow the registered specification and applicable pharmacopoeial requirements. Typical controls may include:
Acceptance criteria such as assay range, dissolution limits and shelf life must come from the approved specification rather than a generic website claim.
Thiamine is converted in the body to active coenzyme forms, including thiamine pyrophosphate, which participate in carbohydrate and energy metabolism and are important for normal nerve and muscle function.
This page does not position a 75 mg oral tablet as a substitute for emergency treatment of severe thiamine deficiency.
B2B registration and export support may include product specifications, analytical documentation and commercial paperwork depending on destination-market requirements and contractual scope.
WHO-GMP, COPP, FSC, Star Export House status, TSE/BSE-free, Non-GMO and specific market approvals should be verified from current documentation before they are used in marketing.
Use according to the approved product label or a healthcare professional's direction. A single universal regimen is not appropriate for all causes and severities of thiamine deficiency.
Exact storage temperature and shelf life should be based on approved stability data for the finished product.
For professional and B2B reference. Product claims, prescribing information, manufacturing statements, certificates and market approvals require verification against the final registered dossier and current documents.